Effect of TRPV2 cation channels on the proliferation, migration and invasion of 5637 bladder cancer cells

Chen, 2012, Cancer incidence and mortality in china, 2007, Chin J Cancer Res, 24, 1, 10.1007/s11670-012-0001-6

Elsobky, 2002, Prognostic value of angiogenesis in schistosoma-associated squamous cell carcinoma of the urinary bladder, Urology, 60, 69, 10.1016/S0090-4295(02)01669-2

Prevarskaya, 2007, Differential role of TRP channels in prostate cancer, Biochem Soc Trans, 35, 133, 10.1042/BST0350133

Caterina, 1999, A capsaicin-receptor homologue with a high threshold for noxious heat, Nature, 398, 436, 10.1038/18906

Neeper, 2007, Activation properties of heterologously expressed mammalian TRPV2: evidence for species dependence, J Biol Chem, 282, 15894, 10.1074/jbc.M608287200

Kanzaki, 1999, Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I, Nat Cell Biol, 1, 165, 10.1038/11086

Everaerts, 2008, On the origin of bladder sensing: Tr(i)ps in urology, Neurourol Urodyn, 27, 264, 10.1002/nau.20511

Nilius, 2007, Transient receptor potential cation channels in disease, Physiol Rev, 87, 165, 10.1152/physrev.00021.2006

Prevarskaya, 2007, TRP channels in cancer, Biochim Biophys Acta, 1772, 937, 10.1016/j.bbadis.2007.05.006

Lehen’kyi, 2011, Study of TRP channels in cancer cells, TRP Channels

Santoni, 2011, TRP channels and cancer: new targets for diagnosis and chemotherapy, Endocr Metab Immune Disord Drug Targets, 11, 54, 10.2174/187153011794982068

Gkika, 2011, TRP channels in prostate cancer: the good, the bad and the ugly?, Asian J Androl, 13, 673, 10.1038/aja.2011.18

Ziglioli, 2009, Vanilloid-mediated apoptosis in prostate cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism, Acta Biomed, 80, 13

Caprodossi, 2008, Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage, Eur Urol, 54, 612, 10.1016/j.eururo.2007.10.016

Yamada, 2010, TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer, Urology, 76, 509.e1, 10.1016/j.urology.2010.03.029

Yang, 2009, Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells, Asian J Androl, 11, 157, 10.1038/aja.2009.1

Caterina, 1997, The capsaicin receptor: a heat-activated ion channel in the pain pathway, Nature, 389, 816, 10.1038/39807

Liedtke, 2000, Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor, Cell, 103, 525, 10.1016/S0092-8674(00)00143-4

Ridley, 2003, Cell migration: integrating signals from front to back, Science, 302, 1704, 10.1126/science.1092053

Monet, 2009, Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation, Biochim Biophys Acta, 1793, 528, 10.1016/j.bbamcr.2009.01.003

Chuang, 2010, Profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases proteins in bladder urothelial carcinoma, Oncol Lett, 1, 691, 10.3892/ol_00000121

Monet, 2010, Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance, Cancer Res, 70, 1225, 10.1158/0008-5472.CAN-09-2205

Kader, 2007, Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness, Clin Cancer Res, 13, 2614, 10.1158/1078-0432.CCR-06-1187

Nakajima, 1993, Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma, Cancer Res, 53, 5802

Stearns, 1993, Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue, Cancer Res, 53, 878

Kanayama, 1998, Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer, Cancer, 82, 1359, 10.1002/(SICI)1097-0142(19980401)82:7<1359::AID-CNCR20>3.0.CO;2-4

Coussens, 2002, Matrix metalloproteinase inhibitors and cancer: trials and tribulations, Science, 295, 2387, 10.1126/science.1067100

Giannelli, 1997, Induction of cell migration by matrix metal-loprotease-2 cleavage of laminin-5, Science, 277, 225, 10.1126/science.277.5323.225

Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat Rev Cancer, 2, 161, 10.1038/nrc745

Noë, 2001, Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1, J Cell Sci, 114, 111, 10.1242/jcs.114.1.111

Mañes, 1999, The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells, J Biol Chem, 274, 6935, 10.1074/jbc.274.11.6935

Stetler-Stevenson, 1999, Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention, J Clin Invest, 103, 1237, 10.1172/JCI6870